Us2.v2 vs KardiaPro

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Us2.v2

by Eko.ai Pte. Ltd d/b/a Us2.ai

KardiaPro

by AliveCor

AI Verdict

Us2.v2 focuses on automating the interpretation and reporting of echocardiograms, providing detailed cardiac measurements and disease detection from ultrasound images. KardiaPro, on the other hand, is a remote patient monitoring platform that manages ECG, blood pressure, and weight data from wearable devices, primarily for arrhythmia detection and trend analysis. While both are cardiology AI tools, Us2.v2 is for in-depth echo analysis, and KardiaPro is for continuous remote patient monitoring.

Choose Us2.v2 if…

Choose Us2.v2 if your primary need is to automate and standardize the interpretation of echocardiograms within a clinical setting, aiming to reduce reporting time and increase scan throughput. This tool is ideal for cardiology departments, core labs, or primary care settings performing cardiac ultrasound, as it delivers a complete structured echo report with measurements, disease detection, and clinical findings, compatible with any ultrasound manufacturer and integrating seamlessly with existing PACS, CVIS, or EMR systems.

View Us2.v2 →

Choose KardiaPro if…

Choose KardiaPro if you need a comprehensive, web-based platform for remote monitoring of patient ECG, blood pressure, and weight data, with FDA-cleared AI for arrhythmia detection. This tool is best suited for healthcare professionals managing chronic cardiac conditions and seeking to analyze patient trends between appointments, as it integrates with personal ECG devices like KardiaMobile and provides a secure platform for efficient data review and informed clinical decision-making.

View KardiaPro →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Us2.v2	KardiaPro
Pricing	Contact for pricing	Contact for pricing
Deployment	Cloud, On-premise	Cloud-hosted, Web-based
FDA Status	1 AI-estimated	1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Us2.v2

Us2.v2 emphasizes 'zero-click analysis' and fully automated reporting, aiming to significantly reduce manual effort and reporting time for echocardiograms. KardiaPro, while offering a user-friendly web-based portal and customizable inbox, still requires patient interaction with KardiaMobile devices for data acquisition.

Clinical Value

Us2.v2

Us2.v2 provides comprehensive, automated echocardiogram interpretation with detection of multiple cardiac diseases and adherence to international guidelines, directly aiding in diagnosis and treatment decisions. KardiaPro focuses on remote monitoring of ECG, blood pressure, and weight data, with FDA-cleared AI for arrhythmia detection, which is valuable for ongoing patient management but less comprehensive for initial diagnosis of a wide range of cardiac conditions.

Pricing & Value

Tie

Both tools require contacting their respective companies for pricing information, making a direct comparison of cost-effectiveness difficult. While KardiaPro mentions being reimbursable using existing CPT codes, Us2.v2 also states that its use within a standard echocardiogram is billed under established CPT codes, with the value lying in faster reporting and higher throughput.

Enterprise Readiness

Us2.v2

Us2.v2 offers both cloud and on-premise deployment options and integrates seamlessly with existing PACS, CVIS, or EMR systems (HL7 and DICOM SR supported), indicating strong enterprise readiness. KardiaPro is cloud-hosted and web-based, with integration capabilities for KardiaMobile devices and KardiaStation, and supports EHR/third-party interoperability, but Us2.v2's explicit mention of on-premise deployment and broader integration standards gives it an edge for larger, more complex healthcare IT environments.

Innovation

Us2.v2

Us2.v2's 'zero-click' 100% AI automation for a complete structured echo report, including advanced measurements like strain analysis and detection of multiple complex cardiac diseases, represents a significant innovation in echocardiography. KardiaPro's innovation lies in its comprehensive remote patient monitoring platform and FDA-cleared AI for arrhythmia detection, which is impactful but less groundbreaking in its core technology compared to Us2.v2's full automation of a highly complex diagnostic imaging modality.

Support & Docs

Tie

Both companies provide limited public information regarding their specific support and documentation offerings beyond general contact for sales or inquiries. Without more detailed information on service level agreements, training programs, or comprehensive documentation portals, it is not possible to definitively pick a winner.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Us2.v2	KardiaPro
Tool Name	Us2.v2	KardiaPro
Company	Eko.ai Pte. Ltd d/b/a Us2.ai	AliveCor
Description	FDA-cleared, AI-powered tool that automates echocardiogram interpretation, delivering a complete structured echo report with measurements, disease detection, and clinical findings, making heart risk detection more accurate, consistent, and accessible worldwide.	A comprehensive web-based portal for remote monitoring of patient ECG, blood pressure, and weight data, with FDA-cleared AI for arrhythmia detection and other cardiac determinations.
Primary Function	AI-Powered Echocardiography Analysis & Reporting	Remote Patient Monitoring and Analysis (ECG, BP, Weight)
Key AI Capabilities	Automated detection of cardiac amyloidosis, aortic stenosis, heart failure, pulmonary hypertension, and valvular disease; 100% AI automation, eliminating manual frame selection and annotation.	FDA-cleared AI for arrhythmia detection
Integrations	PACS, CVIS, or EMR systems (HL7 and DICOM SR supported); Compatible with any ultrasound manufacturer (e.g., GE, Philips, Siemens, handheld POCUS)	KardiaMobile and KardiaMobile 6L devices; KardiaStation for point-of-care solutions
Specialties	Cardiology	Cardiology, Family Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring Us2.v2 and KardiaPro.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows and EHR systems?

Us2.v2 is designed to integrate seamlessly with existing PACS, CVIS, or EMR systems, supporting HL7 and DICOM SR. It processes echocardiograms in real-time and delivers standardized, clinician-ready reports, aiming to reduce reporting time by up to 70% and increase daily scan throughput. KardiaPro, on the other hand, is a web-based portal for remote monitoring that integrates with KardiaMobile and KardiaMobile 6L devices. It offers EHR integration, including availability on Epic's App Orchard Marketplace, to automatically pull ECGs into your EHR system and streamline data review.

What is the accuracy and sensitivity of each tool's AI for disease detection?

Us2.v2 offers 100% AI automation for echocardiogram interpretation, providing measurements, disease detection (cardiac amyloidosis, aortic stenosis, heart failure, pulmonary hypertension, and valvular disease), and clinical findings. Studies have shown Us2.ai's AI echo algorithm can interpret echocardiographic strain images with similar accuracy to conventional measurements and accurately identify patients with heart failure. KardiaPro utilizes FDA-cleared AI for arrhythmia detection. The Kardia algorithm has demonstrated high sensitivity (96.6%) and specificity (94%) for AFib detection compared to expert cardiology over-read of 12-lead EKGs. Kardia devices can detect six common arrhythmias, including AFib, Bradycardia, Tachycardia, Sinus Rhythm with PVCs, Sinus Rhythm with SVE, and Sinus Rhythm with Wide QRS.

What is the typical learning curve for physicians and support quality for each tool?

Us2.v2 aims to reduce the overall time to perform echocardiography and eliminate intra-user variability, suggesting a streamlined process that could imply a lower learning curve for consistent results. It provides explainable AI output with transparent visual overlays and editable outputs, allowing users to evaluate automated annotations and measurements, which can aid in the learning process. KardiaPro is designed for efficient patient monitoring and analysis with a customizable ECG inbox and automated summary reports, suggesting an intuitive interface for managing remote patient data. While specific details on learning curve or support quality are not extensively detailed for either, both aim to simplify complex tasks for healthcare professionals.

How do these tools facilitate multi-site rollouts and customer references?

Us2.v2 is vendor-agnostic, compatible with any ultrasound manufacturer, and integrates with existing PACS, CVIS, or EMR systems, which could facilitate multi-site rollouts across diverse equipment. Its deployment options (cloud and on-premise) also offer flexibility for different institutional IT infrastructures. KardiaPro's web-based portal and EHR integration, including with Epic, suggest a scalable solution for managing patient data across various healthcare settings. While specific customer reference availability for multi-site rollouts isn't detailed, both companies emphasize their commitment to healthcare providers.

What audit-trail features are available in each tool?

Us2.ai (Us2.v2) offers audit logging for all system access and role-based access control, which are crucial for maintaining a comprehensive audit trail. KardiaPro's platform, as part of its SOC 2 and HIPAA compliance, would inherently include audit trail capabilities for tracking data access and modifications, aligning with best practices for data security and accountability.

In what clinical contexts would a physician choose one tool over the other?

A physician would likely choose Us2.v2 for comprehensive, automated echocardiogram interpretation and reporting, especially when needing to detect a range of cardiac conditions like cardiac amyloidosis, aortic stenosis, and heart failure, and to reduce the time and variability associated with manual echo analysis. Conversely, a physician would opt for KardiaPro for remote monitoring of patient ECG, blood pressure, and weight data, particularly for efficient arrhythmia detection and long-term cardiac pattern tracking, enabling informed clinical decisions between appointments.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Us2.v2 or KardiaPro

Backers

Who funded each tool's parent company.